Profile data is unavailable for this security.
About the company
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
- Revenue in CHF (TTM)141.42m
- Net income in CHF-55.88m
- Incorporated2017
- Employees938.00
- LocationIdorsia LtdHegenheimermattweg 91ALLSCHWIL 4123SwitzerlandCHE
- Websitehttps://www.idorsia.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nanobiotix SA | 29.19m | -38.56m | 223.40m | 102.00 | -- | -- | -- | 7.65 | -1.10 | -1.10 | 0.814 | -0.0391 | 0.3912 | -- | 19.59 | 294,686.30 | -51.67 | -54.11 | -120.56 | -80.68 | -- | -- | -132.08 | -756.15 | -- | -1.98 | 1.04 | -- | -- | 203.88 | 30.40 | -- | -7.81 | -- |
| 4Basebio PLC | 580.87k | -8.80m | 230.05m | -- | -- | -- | -- | 396.05 | -0.6222 | -0.6222 | 0.0411 | -0.0399 | 0.0429 | 0.714 | 6.29 | -- | -64.93 | -- | -77.36 | -- | 67.19 | -- | -1,514.82 | -- | 2.06 | -26.66 | 1.05 | -- | 88.81 | -- | -48.83 | -- | -- | -- |
| Ryvu Therapeutics SA | 12.61m | -21.30m | 259.51m | 230.00 | -- | 5.86 | -- | 20.58 | -4.10 | -4.10 | 2.42 | 8.45 | 0.1302 | 12.39 | 4.99 | 241,760.90 | -21.99 | -21.88 | -24.87 | -25.20 | 56.80 | -6.28 | -168.89 | -284.20 | 4.71 | -- | 0.1193 | -- | 20.32 | -9.50 | -9.94 | -- | 53.71 | -- |
| Allergy Therapeutics plc | 61.14m | -57.65m | 259.91m | 635.00 | -- | 8.56 | -- | 4.25 | -0.0266 | -0.0266 | 0.017 | 0.0056 | 0.7571 | 2.21 | 4.92 | 83,870.87 | -71.39 | -11.59 | -102.10 | -15.15 | 52.54 | 70.08 | -94.29 | -11.78 | 0.9281 | -7.93 | 0.2713 | -- | -18.11 | -2.71 | -212.65 | -- | 16.41 | -- |
| Bioventix PLC | 15.61m | 9.95m | 265.15m | 16.00 | 27.11 | 20.20 | 26.28 | 16.99 | 1.63 | 1.63 | 2.56 | 2.19 | 1.09 | 1.53 | 2.54 | 849,780.60 | 69.72 | 56.43 | 79.03 | 61.01 | 93.75 | 92.64 | 63.73 | 65.08 | 6.69 | -- | 0.00 | 84.49 | 9.36 | 7.93 | 9.10 | 8.13 | -37.12 | 20.03 |
| Avacta Group Plc | 26.69m | -28.64m | 279.45m | 154.00 | -- | -- | -- | 10.47 | -0.0914 | -0.0914 | 0.0853 | -- | -- | -- | -- | 150,954.50 | -- | -- | -- | -- | 48.37 | -- | -107.31 | -- | -- | -0.575 | -- | -- | 140.83 | -- | 32.54 | -- | -- | -- |
| Hansa Biopharma AB | 14.18m | -72.24m | 280.99m | 166.00 | -- | -- | -- | 19.81 | -16.07 | -16.07 | 3.15 | -7.10 | 0.1424 | 64.03 | 1.86 | 987,386.90 | -72.51 | -47.96 | -92.27 | -56.12 | 56.80 | 64.18 | -509.33 | -835.04 | 2.55 | -9.65 | 1.65 | -- | -13.22 | 109.06 | -36.09 | -- | -35.24 | -- |
| Selvita SA | 76.47m | 14.81m | 283.03m | 387.00 | 19.12 | 3.81 | 11.07 | 3.70 | 3.56 | 3.56 | 18.37 | 17.83 | 0.553 | 9.29 | 4.70 | 398,178.30 | 10.71 | -- | 12.99 | -- | 79.66 | -- | 19.36 | -- | 1.41 | 11.34 | 0.4063 | -- | -3.48 | -- | 130.55 | -- | -- | -- |
| Nykode Therapeutics ASA | 9.49m | -35.58m | 373.31m | 176.00 | -- | 2.63 | -- | 39.32 | -1.40 | -1.40 | 0.3714 | 5.13 | 0.0534 | -- | 91.80 | 646,936.30 | -20.01 | 5.65 | -22.97 | 6.38 | -- | -- | -374.77 | 18.13 | -- | -- | 0.0313 | -- | 79.99 | 282.17 | 17.75 | -- | 187.37 | -- |
| Oxford BioMedica plc | 102.79m | -180.79m | 398.93m | 714.00 | -- | 4.32 | -- | 3.88 | -1.63 | -1.63 | 0.9273 | 0.7645 | 0.2513 | 3.91 | 3.07 | 125,404.80 | -51.69 | -19.60 | -64.26 | -24.68 | 44.37 | 50.74 | -205.68 | -44.38 | 2.90 | -22.92 | 0.5888 | -- | -36.04 | 6.04 | -302.20 | -- | -0.6307 | -- |
| Idorsia Ltd | 141.42m | -55.88m | 404.65m | 938.00 | -- | -- | -- | 2.86 | -0.3534 | -0.3534 | 0.7363 | -4.97 | 0.1912 | 0.1645 | 113.09 | 150,766.50 | -7.56 | -46.72 | -12.46 | -53.84 | 93.05 | -- | -39.51 | -709.80 | 1.00 | -26.26 | 5.82 | -- | 56.93 | 20.25 | 64.01 | -- | -8.01 | -- |
| Valneva SE | 148.56m | -23.69m | 433.14m | 684.00 | -- | 2.35 | 8.72 | 2.92 | -0.1943 | -0.1943 | 1.10 | 1.36 | 0.2799 | 2.34 | 5.63 | 223,622.80 | -4.46 | -15.39 | -6.84 | -25.06 | 32.95 | 35.94 | -15.95 | -34.95 | 2.22 | -2.69 | 0.528 | -- | -57.46 | 6.34 | 29.21 | -- | 35.18 | -- |
| Kuros Biosciences AG | 33.56m | -13.73m | 435.76m | 80.00 | -- | 7.61 | -- | 12.98 | -0.3697 | -0.3697 | 0.9175 | 1.54 | 0.4347 | 2.40 | 7.27 | 419,550.00 | -17.78 | -13.47 | -21.34 | -14.84 | 71.31 | 78.73 | -40.90 | -81.48 | 1.69 | -84.04 | 0.0364 | -- | 86.61 | 115.93 | 5.95 | -- | -13.21 | -- |
| Puretech Health PLC | 2.98m | -58.88m | 511.34m | 90.00 | -- | 1.40 | -- | 171.32 | -0.1841 | -0.1841 | 0.0093 | 1.33 | 0.0048 | -- | 0.4676 | 28,888.12 | -9.54 | 4.92 | -10.67 | 5.94 | -- | -- | -2,000.84 | 352.67 | -- | -- | 0.0524 | 0.00 | -78.68 | -30.64 | -30.47 | -- | -44.10 | -- |
| Basilea Pharmaceutica AG Allschwil | 157.63m | 10.45m | 522.84m | 147.00 | 45.30 | -- | 43.39 | 3.32 | 0.8765 | 0.8765 | 13.15 | -0.8335 | 0.7999 | 1.06 | 5.16 | 1,072,340.00 | 5.30 | -1.86 | 7.69 | -2.99 | 83.00 | 83.45 | 6.63 | -2.99 | 2.64 | 2.02 | 1.10 | -- | 6.68 | 3.53 | -13.96 | -- | 11.17 | -- |
| Philogen SpA | 22.46m | -5.98m | 582.24m | 160.00 | -- | 9.12 | -- | 25.92 | -0.1551 | -0.1551 | 0.5747 | 2.25 | 0.1887 | 6.65 | 7.95 | 144,562.50 | -5.03 | -7.32 | -5.56 | -8.36 | 40.04 | 32.04 | -26.64 | -58.66 | 6.84 | -- | 0.1414 | -- | -2.46 | 10.80 | -14.60 | -- | 51.78 | -- |
Data as of Jul 05 2024. Currency figures normalised to Idorsia Ltd's reporting currency: Swiss Franc CHF
17.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lazard Asset Management Ltd.as of 13 Jan 2023 | 5.32m | 2.82% |
| Astaris Capital Management LLPas of 25 Apr 2024 | 4.89m | 2.59% |
| Fidelity Management & Research Co. LLCas of 31 May 2024 | 4.71m | 2.49% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 4.39m | 2.33% |
| UBS Asset Management Switzerland AGas of 04 Jun 2024 | 4.24m | 2.24% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 3.17m | 1.68% |
| Credit Suisse Asset Management (Schweiz) AGas of 28 Jun 2024 | 2.68m | 1.42% |
| Z�rcher Kantonalbank (Investment Management)as of 31 May 2024 | 1.82m | 0.97% |
| Rossier, Mari & Associates AGas of 31 Mar 2024 | 1.05m | 0.56% |
| Banque Cantonale de Gen�ve (Investment Management)as of 31 Dec 2023 | 785.56k | 0.42% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
